Implications of fetal stem cell trafficking in pregnancy

Reviews in Gynaecological and Perinatal Practice

Volumn 6, Issue 1-2, 2006, Pages 87-98

  O'Donoghue, Keelin ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

Author keywords

Fetal stem cells; In utero transplantation; Microchimerism; Non invasive prenatal diagnosis; Pregnancy; Trafficking

Indexed keywords

ARTICLE; AUTOIMMUNITY; BONE MARROW; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL PROLIFERATION; CELL TRANSPORT; CELL TYPE; DISEASE PREDISPOSITION; FETOMATERNAL TRANSFUSION; FETOPLACENTAL UNIT; FETUS; FETUS (ANATOMY); FETUS BLOOD; FETUS CELL; GENE THERAPY; GENETIC DISORDER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; MATERNAL BLOOD; MESENCHYMAL STEM CELL; MICROCHIMERISM; MUSCULAR DYSTROPHY; NON INVASIVE MEASUREMENT; OSTEOGENESIS IMPERFECTA; PHENOTYPE; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; STEM CELL; STEM CELL TRANSPLANTATION; SURVIVAL RATE; UMBILICAL CORD BLOOD;

EID: 33747887558     PISSN: 18712320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rigapp.2005.11.001     Document Type: Article

References (61)

1. O'Donoghue K., and Fisk N.M. Fetal stem cells. Best Pract Res Clin Obstet Gynaecol 18 6 (2004) 853-875
2. Marshall C.J., and Thrasher A.J. The embryonic origins of human haematopoiesis. Br J Haematol 112 (2001) 838-850
3. Campagnoli C., Roberts I.A., Kumar S., Bennett P.R., Bellantuono I., and Fisk N.M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98 8 (2001) 2396-2402
4. Campagnoli C., Fisk N.M., Bennett P.R., Overton T.G., and Roberts IA.G. Circulating multipotent haemopoietic progenitors in first trimester fetal blood. Blood 95 (2000) 1967-1972
5. In't Anker P.S., Noort W.A., Scherjon S.A., et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88 8 (2003) 845-852
6. Gussin H.A., Bischoff F.Z., Hoffman R., and Elias S. Endothelial precursor cells in the peripheral blood of pregnant women. J Soc Gynecol Investig 9 6 (2002) 357-361
7. Benirschke K., and Kaufmann P. Pathology of the human placenta. 4th ed. (2000), Springer-Verlag Inc., New York
8. Burton G.J., Jauniaux E., and Watson A.L. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: The Boyd collection revisited. Am J Obstet Gynecol 181 (1999) 718-724
9. Kohnen G., Kertschanska S., Demir R., and Kaufmann P. Placental villous stroma as a model system for myofibroblast differentiation. Histochem Cell Biol 105 (1996) 415-429
10. Devi B., Jennison R.F., and Langley F.A. Significance of placental pathology in transplacental haemorrhage. J Clin Pathol 21 3 (1968) 322-331
11. Sebring E.S., and Polesky H.F. Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects. Transfusion 30 4 (1990) 344-357
12. Bianchi D.W., Williams J.M., Sullivan L.M., Hanson F.W., Klinger K.W., and Shuber A.P. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 61 4 (1997) 822-829
13. Bianchi D.W. Fetomaternal cell traffic, pregnancy-associated progenitor cells, and autoimmune disease. Best Pract Res Clin Obstet Gynaecol 18 6 (2004) 959-975
14. Zilliacus R., De la Chapelle A., Schroder J., Tilikainen A., Kohne E., and Kleihauer E. Transplacental passage of foetal blood cells. Scand J Haematol 15 5 (1975) 333-338
15. Hamada H., Arinami T., Kubo T., Hamaguchi H., and Iwasaki H. Fetal nucleated cells in maternal peripheral blood: frequency and relationship to gestational age. Hum Genet 91 5 (1993) 427-432
16. Price J.O., Elias S., Wachtel S.S., et al. Prenatal diagnosis with fetal cells isolated from maternal blood by multiparameter flow cytometry. Am J Obstet Gynecol 165 6, Part 1 (1991) 1731-1737
17. Thomas M.R., Williamson R., Craft I., Yazdani N., and Rodeck C.H. Y chromosome sequence DNA amplified from peripheral blood of women in early pregnancy. Lancet 343 8894 (1994) 413-414
18. Birch L., English C.A., O'Donoghue K., Barigye O., Fisk N.M., and Keer J.T. Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem 51 2 (2005) 312-320
19. Krabchi K., Gros-Louis F., Yan J., et al. Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques. Clin Genet 60 2 (2001) 145-150
20. Jackson L. Fetal cells and DNA in maternal blood. Prenat Diagn 23 10 (2003) 837-846
21. Bianchi D.W., Farina A., Weber W., et al. Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism. Am J Obstet Gynecol 184 4 (2001) 703-706
22. Artlett C.M. Pathophysiology of fetal microchimeric cells. Clin Chim Acta 360 1-2 (2005) 1-8
23. Liegeois A., Gaillard M.C., Ouvre E., and Lewin D. Microchimerism in pregnant mice. Transplant Proc 13 1, Part 2 (1981) 1250-1252
24. Ando T., and Davies T.F. Self-recognition and the role of fetal microchimerism. Best Pract Res Clin Endocrinol Metab 18 2 (2004) 197-211
25. Gotherstrom C., Ringden O., Tammik C., Zetterberg E., Westgren M., and Le Blanc K. Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 190 1 (2004) 239-245
26. Nelson J.L. HLA relationships of pregnancy, microchimerism and autoimmune disease. J Reprod Immunol 52 (2001) 77-84
27. Opelz G., Mickey M.R., and Terasaki P.I. Blood transfusions and unresponsiveness to HL-A. Transplantation 16 6 (1973) 649-654
28. Opelz G., Sengar D.P., Mickey M.R., and Terasaki P.I. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 5 1 (1973) 253-259
29. Ober C. HLA and pregnancy: the paradox of the fetal allograft. Am J Hum Genet 62 1 (1998) 1-5
30. Schonland S.O., Lopez C., Widmann T., et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA 100 23 (2003) 13471-13476
31. Nelson J.L., Hughes K.A., Smith A., Nisperos B.B., Branchaud A.M., and Hansen J.A. Maternal-fetal disparity in HLA-Class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. New Eng J Med 329 7 (1993) 466-471
32. O'Donoghue K., Choolani M., Chan J., et al. Identification of fetal mesenchymal stem cells in maternal blood: implications for non-invasive prenatal diagnosis. Mol Hum Reprod 9 8 (2003) 497-502
33. Bianchi D.W., Simpson J.L., Jackson L.G., et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. Prenat Diagn 22 (2002) 609-615
34. Guetta E., Gordon D., Simchen M.J., Goldman B., and Barkai G. Hematopoietic progenitor cells as targets for non-invasive prenatal diagnosis: detection of fetal CD34+ cells and assessment of post-delivery persistence in the maternal circulation small star, filled. Blood Cells Mol Dis 30 1 (2003) 13-21
35. Tocci A., Roberts I.A., Kumar S., Bennett P.R., and Fisk N.M. CD34+ cells from first-trimester fetal blood are enriched in primitive hemopoietic progenitors. Am J Obstet Gynecol 188 4 (2003) 1002-1010
36. Lansdorp P.M., Dragowska W., and Mayani H. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 178 3 (1993) 787-791
37. Campagnoli C., Roberts IAG, Kumar S., et al. Expandability of haemopoietic progenitors in first trimester fetal and maternal blood: implications for non-invasive prenatal diagnosis. Prenat Diagn 22 6 (2002) 463-469
38. Valerio D., Aiello R., Altieri V., Malato A.P., Fortunato A., and Canazio A. Culture of fetal erythroid progenitor cells from maternal blood for non-invasive prenatal genetic diagnosis. Prenat Diagn 16 12 (1996) 1073-1082
39. Jansen M.W., Korver-Hakkennes K., van Leenen D., et al. How useful is the in vitro expansion of fetal CD34+ progenitor cells from maternal blood samples for diagnostic purposes?. Prenat Diagn 20 9 (2000) 725-731
40. Bohmer R.M., Stroh H.P., Johnson K.L., LeShane E.S., and Bianchi D.W. Fetal Cell Isolation from maternal blood cultures by flow cytometric hemoglobin profiles. Results of a preliminary clinical trial. Fetal Diagn Ther 17 2 (2002) 83-89
41. Little M.T., Langlois S., Wilson R.D., and Lansdorp P.M. Frequency of fetal cells in sorted subpopulations of nucleated erythroid and CD34+ hematopoietic progenitor cells from maternal peripheral blood. Blood 89 7 (1997) 2347-2358
42. Liechty K.W., MacKenzie T.C., Shaaban A.F., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6 11 (2000) 1282-1286
43. MacKenzie T.C., and Flake A.W. Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Cells Mol Dis 27 3 (2001) 601-604
44. Le Blanc K., Gotherstrom C., Ringden O., et al. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79 11 (2005) 1607-1614
45. Chan J., O'Donoghue K., de la Fuente J., et al. Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 23 1 (2005) 93-102
46. Orlandi F., Damiani G., Jakil C., Lauricella S., Bertolino O., and Maggio A. The risks of early cordocentesis (12-21 weeks): analysis of 500 procedures. Prenat Diagn 10 7 (1990) 425-428
47. Surbek D.V., Young A., Danzer E., Schoeberlein A., Dudler L., and Holzgreve W. Ultrasound-guided stem cell sampling from the early ovine fetus for prenatal ex vivo gene therapy. Am J Obstet Gynecol 187 4 (2002) 960-963
48. Devine S.M., Bartholomew A.M., Mahmud N., et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 29 2 (2001) 244-255
49. Srivatsa B., Srivatsa S., Johnson K.L., Samura O., Lee S.L., and Bianchi D.W. Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet 358 9298 (2001) 2034-2038
50. Bianchi D.W., Zickwolf G.K., Weil G.J., Sylvester S., and DeMaria M.A. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 93 2 (1996) 705-708
51. Khosrotehrani K., and Bianchi D.W. Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci 118 Part 8 (2005) 1559-1563
52. O'Donoghue K., Chan J., de la Fuente J., et al. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet 364 9429 (2004) 179-182
53. Khosrotehrani K., Johnson K.L., Lau J., Dupuy A., Cha D., and Bianchi D.W. The influence of fetal loss on the presence of fetal cell microchimerism. Arthritis Rheum 48 11 (2003) 3237-3241
54. Aractingi S., Berkane N., Bertheau P., et al. Fetal DNA in skin of polymorphic eruptions of pregnancy. Lancet 352 9144 (1998) 1898-1901
55. Nelson J.L. Pregnancy and microchimerism in autoimmune disease: protector or insurgent?. Arthritis Rheum 46 2 (2002) 291-297
56. Wang Y., Iwatani H., Ito T., et al. Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury. Biochem Biophys Res Commun 325 3 (2004) 961-967
57. Willer C.J., Sadovnick A.D., and Ebers G.C. Microchimerism in autoimmunity and transplantation: potential relevance to multiple sclerosis. J Neuroimmunol 126 1-2 (2002) 126-133
58. Flowers M.E., Pepe M.S., Longton G., et al. Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation. Br J Haematol 74 4 (1990) 492-496
59. Mahanty H.D., Cherikh W.S., Chang G.J., Baxter-Lowe L.A., and Roberts J.P. Influence of pretransplant pregnancy on survival of renal allografts from living donors. Transplantation 72 2 (2001) 228-232
60. Adams K.M., Lambert N.C., Heimfeld S., et al. Male DNA in female donor apheresis and CD34-enriched products. Blood 102 10 (2003) 3845-3847
61. Rinkevich B. Human natural chimerism: an acquired character or a vestige of evolution?. Hum Immunol 62 6 (2001) 651-657